Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

A protein from fat-derived stem cells, DKK1, is linked to hair loss and blocking it may help treat alopecia areata.

Topical treatments led to hair regrowth in a man with linear morphea.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Epigenetic factors play a crucial role in skin health and disease.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Tiny particles called extracellular vesicles show promise for treating skin conditions and promoting hair growth.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.